--- title: "TFA Therapeutics (RAJAF) stock: news and investor profile" url: "https://aibio.space/companies/tfa-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TFA Therapeutics, Inc. (OTC: RAJAF), United States. Listing facts, related biotech companies and news on aibio.space." --- RAJAF TFA Therapeutics, Inc. OTC · United States # TFA Therapeutics (RAJAF) news TFA Therapeutics, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker RAJAF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest TFA Therapeutics news We have not published a story on TFA Therapeutics yet. When there is news, it will appear here. ## TFA Therapeutics at a glance - **Ticker**: RAJAF - **Listing**: OTC - **Country**: United States - **Cash, Dec 31, 2025**: $3,199 ### Related companies - [PAVmed](https://aibio.space/companies/pavmed/) NASDAQ: PAVM - [VivoSim Labs, INC.](https://aibio.space/companies/vivosim-labs/) NASDAQ: VIVS - [INTUITIVE SURGICAL INC](https://aibio.space/companies/intuitive-surgical/) NASDAQ: ISRG - [ORASURE TECHNOLOGIES INC](https://aibio.space/companies/orasure-technologies/) NASDAQ: OSUR - [Stevanato Group S.p.A.](https://aibio.space/companies/stevanato-s-p-a/) NYSE: STVN - [WEED, INC.](https://aibio.space/companies/weed/) OTC: BUDZ - [Stereotaxis](https://aibio.space/companies/stereotaxis/) NYSE: STXS - [One World Products](https://aibio.space/companies/one-world-products/) OTC: OWPC ### Also on OTC - [CYANOTECH CORP](https://aibio.space/companies/cyanotech/) CYAN - [Sigyn Therapeutics](https://aibio.space/companies/sigyn-therapeutics/) SIGY - [Asep Medical Holdings](https://aibio.space/companies/asep-medical/) SEPSF - [LianBio](https://aibio.space/companies/lianbio/) LIANY - [Applied Biosciences](https://aibio.space/companies/applied-biosciences/) APPB - [Retrieve Medical Holdings](https://aibio.space/companies/retrieve-medical/) RMHI ## TFA Therapeutics annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$1.2 million](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | [$1.3 million](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | | Net income (loss) | [-$154,822](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | [-$226,258](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | | Cash from operations | [-$35,845](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | [$312,006](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | | Cash and equivalents | [$3,199](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | [$37,284](https://www.sec.gov/Archives/edgar/data/1885680/000121390026057774/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $3,199. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about TFA Therapeutics What is the ticker symbol of TFA Therapeutics? TFA Therapeutics, Inc. trades under the ticker RAJAF on OTC. Where is TFA Therapeutics listed? TFA Therapeutics, Inc. is listed on OTC. Which country or territory is TFA Therapeutics listed under? Our directory records TFA Therapeutics, Inc. under United States. Does aibio.space cover TFA Therapeutics? aibio.space lists TFA Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was TFA Therapeutics's revenue last year? $1.2 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is TFA Therapeutics profitable? TFA Therapeutics, Inc. reported a net loss of $154,822 for the fiscal year ended Dec 31, 2025, and used $35,845 of cash in operations, per its annual report to the SEC. How much cash does TFA Therapeutics have? $3,199 in cash at Dec 31, 2025, per its 20-F. ## Investor discussion: TFA Therapeutics Members talk about TFA Therapeutics (RAJAF). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at TFA Therapeutics, newest first. Each line links the filing it comes from. 1. 2026-09-02 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1885680/000121390026096447/ea030418701ex99-1.htm) 2. 2026-04-30 Distress Told the SEC a periodic report would be filed late. SEC Form NT 20-F. [Source](https://www.sec.gov/Archives/edgar/data/1885680/000121390026050286/ea0288359-nt20f_cordyceps.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:RAJAF on TradingView](https://www.tradingview.com/symbols/OTC-RAJAF/). ## Listing details TFA Therapeutics, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker RAJAF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: TFA Therapeutics, Inc. - **Ticker**: RAJAF - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tfa-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TFA Therapeutics (RAJAF) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/tfa-therapeutics/